Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
August 07 2008 - 4:12PM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., Aug. 7 /PRNewswire-FirstCall/ --
Monogram Biosciences, Inc. (NASDAQ:MGRM) announced today that
William D. Young, CEO and Chairman, is scheduled to present an
update on the company's business at the Thomas Weisel Partners
Healthcare Conference on Wednesday, September 3, 2008 at 11:30 a.m.
(Eastern Time) at the Four Seasons Hotel in Boston, MA. To access
the live audio broadcast or the subsequent archived recording, log
on to http://www.monogrambio.com/ and go to the investor relations
section ("Investors/Media" tab) and click on the "Events &
Webcasts" link provided on the sidebar menu on the page. About
Monogram Biosciences, Inc. Monogram is advancing individualized
medicine by discovering, developing and marketing innovative
products to guide and improve treatment of serious infectious
diseases and cancer. The Company's products are designed to help
doctors optimize treatment regimens for their patients that lead to
better outcomes and reduced costs. The Company's technology is also
being used by numerous biopharmaceutical companies to develop new
and improved antiviral therapeutics and vaccines as well as
targeted cancer therapeutics. More information about the Company
and its technology can be found on its web site at
http://www.monogrambio.com/. Contacts: Alfred G. Merriweather Chief
Financial Officer Tel: 650 624-4576 Jeremiah Hall Feinstein Kean
Healthcare Tel: 415 677-2700 DATASOURCE: Monogram Biosciences, Inc.
CONTACT: Alfred G. Merriweather, Chief Financial Officer,
+1-650-624-4576, ; or Jeremiah Hall, Feinstein Kean Healthcare,
+1-415-677-2700, Web site: http://www.monogrambio.com/
Copyright
Monogram Technologies (NASDAQ:MGRM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Monogram Technologies (NASDAQ:MGRM)
Historical Stock Chart
From Jul 2023 to Jul 2024